Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Katerina Antoniou (Heraklion, Crete, Greece), Eliza Tsitoura, Athol U. Wells, Chara Koutoulaki, Konstantinos Karagiannis, Ismini Lasithiotaki, Eirini Vasarmidi, Hiroe Sato, Demetrios A. Spandidos, Nikolaos M. Siafakas, Georgios Sourvinos, Katerina Antoniou. MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF alveolar macrophages. Eur Respir J 2016; 48: Suppl. 60, 2094

Member's Comments

No comment yet.

Related content which might interest you: Expression of macrophage migration inhibitory factor in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Role of macrophage activation in type II alveolar cells transplantation for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 The RANKL-OPG balance in pulmonary fibrosis Source: International Congress 2015 – Connective tissue disorders Year: 2015 CFTR-dependent deficiency in alternatively-activated macrophages in cystic fibrosis Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Pirfenidone suppresses proinflammatory and antiangiogenetic cytokine production by alveolar macrophages (AMs) in idiopathic non specific interstitial pneumonia (iNSIP) Source: International Congress 2014 – ILDs 2 Year: 2014 Identification of profibrotic cells in the Idiopathic Pulmonary Fibrosis (IPF) lung Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Characterization of M1 and M2 macrophages in human lung tissue Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Alveolar type II cells transplantation in pulmonary fibrosis: Effect on the lung macrophage activation Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Impaired HGF-production by alveolar macrophages is a feature of diabetic pneumonia Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Functional phenotype of immune response and alveolar macrophages phenotype in pulmonary sarcoidosis Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Oxidative stress drives defective efferocytosis in COPD M2-like macrophages Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Induced pluripotent stem cells conditioned media (iPS-cm) modulates macrophage phenotype in the fibrotic lung Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Neutrophil chemotaxis and adhesion in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2001; 18: Suppl. 33, 108s Year: 2001 Elevated GM-CSF in COPD may drive defective macrophage phenotype Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Pulmonary alveolar proteinosis: iPS derived macrophages as in-vitro disease model and potential source for novel gene and cell therapies Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 M2 polarized alveolar macrophages in pulmonary fibrosis Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 Increased apoptosis of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF). Potential mechanisms and practical considerations Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Clinical and functional features in idiopathic pulmonary fibrosis (IPF) with and without haemosiderin-laden alveolar macrophages on BALF Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Impaired monocyte chemotaxis in COPD Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015